ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Recursos principais

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Vornado Realty Trust

Vornado Realty Trust (VNO)

42,43
-0,19
(-0,45%)
Fechado 05 Janeiro 6:00PM
42,43
0,00
(0,00%)
Após o horário de negociação: 8:55PM

Calls

StrikeOfertaVendaÚltimo PreçoPonto MédioVariação do DiaVariação do Dia %VolumeINT ABERTOÚltimo Negócio
30,0012,3012,7012,1712,500,272,27 %215303/01/2025
32,0010,1011,0013,0710,550,000,00 %01-
34,007,809,8010,208,80-0,000,00 %00-
35,005,707,907,836,80-2,07-20,91 %412903/01/2025
36,004,808,606,956,700,000,00 %00-
37,004,008,007,206,000,000,00 %05-
38,002,656,004,104,3250,000,00 %010-
39,001,705,604,203,650,6016,67 %101003/01/2025
40,002,603,302,702,95-0,15-5,26 %3063.60803/01/2025
41,001,902,151,602,0250,000,00 %010-
42,001,251,451,151,350,000,00 %0161-
43,000,750,951,000,850,000,00 %042-
44,000,400,600,700,500,000,00 %0493-
45,000,200,350,400,275-0,01-2,44 %289903/01/2025
46,000,100,250,250,1750,000,00 %025-
47,000,052,150,081,100,000,00 %0139-
48,000,211,950,211,080,000,00 %0502-
49,000,141,350,140,7450,000,00 %0526-
50,000,070,150,070,110,000,00 %0248-
55,000,500,750,500,6250,000,00 %01-

Seu centro para cotações em tempo real, discussões ao vivo e novas ideias.

Puts

StrikeOfertaVendaÚltimo PreçoPonto MédioVariação do DiaVariação do Dia %VolumeINT ABERTOÚltimo Negócio
30,000,090,050,090,070,000,00 %01.040-
32,000,050,300,050,1750,000,00 %0671-
34,000,120,350,120,2350,000,00 %08-
35,000,050,150,050,100,000,00 %0870-
36,000,271,350,270,810,000,00 %021-
37,000,371,400,370,8850,000,00 %0478-
38,000,050,150,330,100,000,00 %0294-
39,000,150,250,450,200,000,00 %032-
40,000,250,400,350,325-0,05-12,50 %25053003/01/2025
41,000,450,651,100,550,000,00 %0161-
42,000,801,201,001,00-0,60-37,50 %210003/01/2025
43,000,754,001,452,375-0,70-32,56 %12.29403/01/2025
44,000,502,951,351,7250,000,00 %0104-
45,001,505,203,983,350,000,00 %033-
46,002,205,902,154,050,000,00 %032-
47,002,806,900,004,850,000,00 %00-
48,004,007,404,105,700,000,00 %0750-
49,004,508,704,106,600,000,00 %01-
50,005,509,500,007,500,000,00 %00-
55,0010,3014,800,0012,550,000,00 %00-

Rankings

Ver todos
  • Volume
  • % Altas
  • % Quedas
CódigoPreçoVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
CRNCCerence Inc
US$ 19,33
(143,76%)
161,8M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,8M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
161,15k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
1,04M
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,59M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
337,5M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
230,01M
Mr. Bill Mr. Bill 9 minutos atrás
https://www.medicinenet.com/what_are_blood_oxygen_levels/article.htm
devil dog 96 devil dog 96 10 minutos atrás
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 10 minutos atrás
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 14 minutos atrás
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 14 minutos atrás
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 34 minutos atrás
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 37 minutos atrás
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 38 minutos atrás
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 38 minutos atrás
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 39 minutos atrás
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 40 minutos atrás
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 41 minutos atrás
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 42 minutos atrás
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 43 minutos atrás
Probably
AVXL
HokieHead HokieHead 46 minutos atrás
Wrong..
TWOH
HokieHead HokieHead 46 minutos atrás
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 47 minutos atrás
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 49 minutos atrás
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 49 minutos atrás
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 50 minutos atrás
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 51 minutos atrás
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 52 minutos atrás
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 52 minutos atrás
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM

Seu Histórico Recente